Compare ARK Genomic Revolution ETF (ARKG) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? ARK Genomic Revolution ETF trades at $41, while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $33.17. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Direxion Daily 20 Year Treasury Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| ARKG | TMF | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $44.14 |
52-Week Low | $23.09 | $31.85 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
TMF trades at $33.42, showing minimal daily movement with a slight decline of 0.06%. The technical outlook is bearish with moving averages signaling strong selling pressure, though oscillators remain neutral. Recent news highlights significant long-term underperformance, with a $10,000 investment five years ago now worth approximately $1,527, emphasizing the leveraged ETF's high-risk nature.
The outlook for TMF remains challenging due to its leveraged structure and bearish technical signals. Investment opportunities exist for short-term traders betting on bond market rebounds, but risks include daily leverage decay, interest rate volatility, and the ETF's unsuitability for long-term holdings. Caution is warranted given the amplified loss potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Direxion Daily 20 Year Treasury Bull 3X Shares
TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →
